Virios therapeutics to present at the h.c. wainwright global life sciences conference in march 2021

Atlanta--(business wire)--virios therapeutics, inc. (nasdaq: viri), a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with virally triggered or maintained immune responses, announced today that greg duncan, chairman and chief executive officer, will present a company overview at the h.c. wainwright global life sciences conference, which is taking place march 9 - 10, 2021. the presentation will focus on the need for new approaches
VIRI Ratings Summary
VIRI Quant Ranking